On May 19, shares in the First Capital Inc. company were selling at $25.07.
First Capital Inc. employs 184 people and has reported $13,190,000 in income as of May 19.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | % of Change in Last Year | Selling Price |
|---|---|---|
| Freedom Holdings Inc. | 3,263.64% | $0.37 |
| Bravo Multinational Inc. | 1,840.1% | $0.745 |
| Digital Brand Media & Marketing Group Inc. | 1,140.74% | $0.0067 |
| Ameritek Ventures Inc | 786.67% | $0.0133 |
| Bellerophon Therapeutics Inc. | 661.54% | $7.92 |
| Cabaletta Bio Inc. | 618.52% | $11.64 |
| Immunovant Inc. | 485.91% | $21.21 |
| 89Bio Inc. | 468.23% | $16.99 |
| Arcellx Inc | 442.02% | $41.41 |
| Ardelyx Inc. | 425.93% | $3.55 |
| Biomea Fusion Inc. | 425.7% | $31.7 |
| Akero Therapeutics Inc. | 407.8% | $45.6 |
| Atlas Lithium Corp | 396.52% | $21.04 |
| Dinewise Inc. | 390.69% | $0.0785 |
| Cymabay Therapeutics Inc. | 379.47% | $9.11 |
| Clearone Inc. | 352.21% | $2.55 |
| Blue Dolphin Energy Co. | 350.46% | $3.21 |
| Elf Beauty Inc. | 319.67% | $89.81 |
| Aehr Test Systems | 303.92% | $32.96 |
| Enliven Therapeutics Inc | 303.8% | $20.19 |
| ImmunoGen Inc. | 303.68% | $14.25 |
| Aldeyra Therapeutics Inc. | 275.95% | $9.85 |
| Aldeyra Therapeutics Inc. | 275.95% | $9.85 |
| Harrow Health Inc. | 269.5% | $21.32 |
| Findit Inc. | 252.35% | $0.0599 |
| Cannabis Suisse Corp. | 236.54% | $0.07 |
| Akebia Therapeutics Inc | 235.26% | $1.16 |
| Astria Therapeutics Inc. | 232.89% | $12.65 |
| Burzynski Research Institute Inc. | 232% | $0.0498 |
| GlycoMimetics Inc. | 221.74% | $1.98 |
| Corvus Pharmaceuticals Inc. | 198.13% | $3.19 |
| Amylyx Pharmaceuticals Inc | 196.01% | $26.7 |
| Muscle Maker Inc. | 188.99% | $1.11 |
| Applied Digital Corp | 177.35% | $8.57 |
| Heritage Global Inc. | 177.31% | $3.3 |
| Bel Fuse Inc. | 177.21% | $45.74 |
| Bel Fuse Inc. | 177.21% | $45.74 |
| Hims & Hers Health Inc. | 175.21% | $9.77 |
| Cidara Therapeutics Inc | 173.74% | $1.3 |
| Accustem Sciences Ltd | 171.93% | $1.55 |
| CVRx Inc. | 165.15% | $13.39 |
| BrightRock Gold Corp. | 160.73% | $0.3903 |
| Professional Diversity Network Inc. | 158.82% | $4.4 |
| Array Technologies Inc. | 156.71% | $23.13 |
| EMagin Corp. | 156.51% | $2 |
| Dyne Therapeutics Inc. | 152.3% | $13.7 |
| Eline Entertainment Group Inc | 150% | $0.0005 |
| Apptech Corp. | 149.44% | $1.91 |
| Axcelis Technologies Inc. | 147.23% | $141.59 |
| A1 Group Inc. | 146.48% | $0.0175 |